Latest filings (excl ownership)
15-12G
Securities registration termination
22 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jul 19
8-K
MYnd Analytics and Emmaus Life Sciences Stockholders Approve Merger and Spin-off Transactions
11 Jul 19
8-K
Emmaus Life Sciences Announces Initiation of its Diverticulosis Study
8 Jul 19
DEFA14A
Additional proxy soliciting materials
8 Jul 19
8-K
Emmaus Life Sciences Announces Hiring of New EndariĀ® Product Manager
3 Jul 19
DEFA14A
Additional proxy soliciting materials
3 Jul 19
8-K
Other Events
24 Jun 19
DEFA14A
Additional proxy soliciting materials
24 Jun 19
DEFM14A
Proxy related to merger
14 Jun 19
425
Business combination disclosure
30 May 19
8-K
Emmaus Life Sciences Announces New CFO and EMA Opinion
30 May 19
10-Q
2019 Q1
Quarterly report
14 May 19
D
Indefinite amount in equity / options / securities to be acquired, sold $2.59M, 7 investors
1 Apr 19
10-K
2018 FY
Annual report
21 Mar 19
8-K
Emmaus Life Sciences Signs Agreement with Express Scripts
11 Mar 19
DEFA14A
Additional proxy soliciting materials
11 Mar 19
425
Business combination disclosure
4 Feb 19
425
Business combination disclosure
29 Jan 19
425
Business combination disclosure
24 Jan 19
425
Business combination disclosure
10 Jan 19
DEFA14A
Additional proxy soliciting materials
7 Jan 19
8-K
MYnd Analytics and Emmaus Life Sciences Announce Merger and Spin-off Transaction
7 Jan 19
425
Business combination disclosure
7 Jan 19
8-K
Amendments to Articles of Incorporation or Bylaws
20 Dec 18
S-8
Registration of securities for employees
30 Nov 18
10-Q
2018 Q3
Quarterly report
14 Nov 18
D
$12.2M in debt / options / securities to be acquired / Common Stock, sold $12.2M, 18 investors
1 Nov 18
8-K
Entry into a Material Definitive Agreement
15 Oct 18
8-K/A
Entry into a Material Definitive Agreement
5 Oct 18
8-K
Departure of Directors or Certain Officers
28 Sep 18
8-K
Entry into a Material Definitive Agreement
17 Sep 18
DEF 14A
Definitive proxy
23 Aug 18
10-Q
2018 Q2
Quarterly report
14 Aug 18
8-K
Departure of Directors or Certain Officers
19 Jul 18
8-K
Departure of Directors or Certain Officers
18 Jun 18
10-Q
2018 Q1
Quarterly report
15 May 18
10-K
2017 FY
Annual report
16 Apr 18
8-K
Entry into a Material Definitive Agreement
4 Apr 18
NT 10-K
Notice of late annual filing
3 Apr 18
Latest ownership filings
SC 13D/A
EMI Holding, Inc.
1 Aug 19
4
Wei Peu ZEN
12 Jul 19
4
Yutaka Niihara
11 Jul 19
4
Joseph Charles Sherwood III
21 Jun 19
3
Joseph Charles Sherwood III
3 Jun 19
4
Yutaka Niihara
31 May 19
4
Change in insider ownership
7 Mar 19
SC 13D/A
Emmaus Life Sciences, Inc.
14 Jan 19
3/A
Wei Peu ZEN
21 Dec 18
4
Wei Peu ZEN
20 Dec 18
4
Yutaka Niihara
14 Dec 18
SC 13D/A
Emmaus Life Sciences, Inc.
14 Dec 18
3
Robert IV Dickey
28 Sep 18
4
Kurt H Kruger
16 Aug 18
3
Wei Peu ZEN
3 Aug 18
3
Kurt H Kruger
26 Jul 18
SC 13D
Emmaus Life Sciences, Inc.
9 May 18
3
Initial statement of insider ownership
8 May 18
SC 13D/A
Emmaus Life Sciences, Inc.
13 Apr 18
SC 13D/A
Emmaus Life Sciences, Inc.
3 Apr 18
4
Masaharu Osato
5 Mar 18
4
Jon Kuwahara
5 Mar 18
4
Ian Harvey Zwicker
5 Mar 18
4
Yutaka Niihara
17 Nov 16
SC 13D
Emmaus Life Sciences, Inc.
14 Oct 16
3
Initial statement of insider ownership
12 Oct 16
4/A
Jon Kuwahara
3 Jun 16
4/A
Ian Harvey Zwicker
3 Jun 16
4/A
Masaharu Osato
3 Jun 16
4
Yutaka Niihara
26 May 16
4
Masaharu Osato
13 May 16
4
WILLIS C LEE
12 May 16
4
Lan T. Tran
12 May 16
4
Ian Harvey Zwicker
12 May 16
4
YASUSHI NAGASAKI
12 May 16
4
Peter Ludlum
12 May 16
4
Jon Kuwahara
12 May 16
3
Sangho Steve Lee
4 May 16
4
Lan T. Tran
22 Mar 16
4
Ian Harvey Zwicker
22 Mar 16